PCSK9 and coronary artery disorder: Furthermore, platelet expression of P-selectin, levels of activated GP IIb/IIIa, and circulating platelet-leucocytes aggregates in response to injury were lower in PCSK9 −/− mice than in the non-mutant controls, pointing to a mechanism by which the loss of PCSK9 protects against coronary artery disease [58].